Alaunos Therapeutics (TCRT) FCF Margin (2016 - 2025)
Historic FCF Margin for Alaunos Therapeutics (TCRT) over the last 13 years, with Q1 2025 value amounting to 38600.0%.
- Alaunos Therapeutics' FCF Margin rose 1531000000.0% to 38600.0% in Q1 2025 from the same period last year, while for Sep 2025 it was 48483.33%, marking a year-over-year increase of 1475833300.0%. This contributed to the annual value of 49710.0% for FY2024, which is 5570700000.0% up from last year.
- According to the latest figures from Q1 2025, Alaunos Therapeutics' FCF Margin is 38600.0%, which was up 1531000000.0% from 14800.0% recorded in Q4 2024.
- In the past 5 years, Alaunos Therapeutics' FCF Margin ranged from a high of 220.1% in Q3 2022 and a low of 774250.0% during Q4 2021
- Over the past 5 years, Alaunos Therapeutics' median FCF Margin value was 52821.59% (recorded in 2022), while the average stood at 204363.75%.
- Its FCF Margin has fluctuated over the past 5 years, first tumbled by 2000000000bps in 2023, then skyrocketed by 2000000000bps in 2024.
- Over the past 5 years, Alaunos Therapeutics' FCF Margin (Quarter) stood at 774250.0% in 2021, then skyrocketed by 92bps to 63618.18% in 2022, then crashed by -1061bps to 738500.0% in 2023, then soared by 98bps to 14800.0% in 2024, then crashed by -161bps to 38600.0% in 2025.
- Its last three reported values are 38600.0% in Q1 2025, 14800.0% for Q4 2024, and 42025.0% during Q2 2024.